Home › Therapeutic areas › Infectious Disease › Mycobacterium avium Complex Lung Disease

Mycobacterium avium Complex Lung Disease (1 companies)

Companies with an active program in Mycobacterium avium Complex Lung Disease.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
INSM	Insmed	CardiovascularImmunology+3 Rare	2	Approved	$25.1B	15